Показано 0 из 0
Дата |
---|
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.32
|
4.42
|
4.22
|
4.22
|
4.22
|
4.22
|
|
|
|
|
4.22
|
4.32
|
3.96
|
3.96
|
3.96
|
3.96
|
|
|
|
|
4.02
|
4.14
|
3.76
|
3.76
|
3.76
|
3.76
|
|
|
|
|
4.00
|
4.10
|
4.26
|
4.26
|
4.26
|
4.26
|
|
|
|
|
4.16
|
4.30
|
4.02
|
4.02
|
4.02
|
4.02
|
|
|
|
|
4.22
|
4.34
|
3.28
|
3.28
|
3.28
|
3.28
|
|
|
|
|
3.42
|
3.52
|
3.26
|
3.26
|
3.26
|
3.26
|
|
|
|
|
3.00
|
3.10
|
3.16
|
3.16
|
3.16
|
3.16
|
|
|
|
|
3.18
|
3.28
|
3.02
|
3.02
|
3.02
|
3.02
|
|
|
|
|
3.06
|
3.14
|
3.00
|
3.00
|
3.00
|
3.00
|
|
|
|
|
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.